| Hebei Aoxing Group Pharmaceutical Co., Ltd. | | The holding company of Hebei Aoxing Group Pharmaceutical Co., Ltd. is Oster Company (US) which has been listed on NASDQ and whose headquarters is at 100 Wall Street, New York City. Located in Xinle Industrial Zone, the production base covers a land area of 200 thousand m2, with total investment of US $48 million. The first stage investment is US $23 million. So far the workshops have been completed for chemical synthesis, TCM extraction, capsule & tablet, injection, and granule. The company is mainly engaged in the production of anesthetic. So far the three preparation types of naloxone have obtained approval from State Food and Drug Administration and the other four types are in the process of application. | |
|
|
